MAPT and Alzheimer disease: However, therapeutic compounds tested for AD have failed to yield significant results (6), and there is mounting evidence suggesting that neuroinflammation, as a third pathological mechanism, precedes the formation of amyloid Aβ and tau protein hyperphosphorylation (7–9).